NEW MJ NEWS

AbbVie to Present at the RBC Capital Markets Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 3:50 p.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-rbc-capital-markets-global-healthcare-conference-301289262.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cresco Labs Inc. (CRLBF) to Report First Quarter 2021 Financial Results on May 27th

Cresco Labs to Report First Quarter 2021 Financial Results on May 27th…

Verano Holdings Corp. (VRNOF) Launches Cabbage Club™, Disrupting the Current Cannabis Retail Landscape

Verano Launches Cabbage Club™, Disrupting the Current Cannabis Retail Landscape with Industry-First…

$MCIG Reports Positive Operating Cash Flow

mCig(R), Inc. Reports Positive Operating Cash Flow 240% Increase in Quarterly Revenue…

Dewmar International BMC, Inc. (DEWM) Files Provisional Patent to Treat Lung Cancer With Cannabinoids

Dewmar International BMC, Inc. (DEWM) Files Provisional Patent to Treat Lung Cancer…